1. RopersHH (2010) Genetics of early onset cognitive impairment. Annu Rev Genomics Hum Genet 11: 161–187.
2. de LigtJ, WillemsenMH, van BonBW, KleefstraT, YntemaHG, et al. (2012) Diagnostic exome sequencing in persons with severe intellectual disability. N Engl J Med 367: 1921–1929.
3. HamdanFF, GauthierJ, ArakiY, LinDT, YoshizawaY, et al. (2011) Excess of de novo deleterious mutations in genes associated with glutamatergic systems in nonsyndromic intellectual disability. Am J Hum Genet 88: 306–316.
4. RauchA, WieczorekD, GrafE, WielandT, EndeleS, et al. (2012) Range of genetic mutations associated with severe non-syndromic sporadic intellectual disability: an exome sequencing study. Lancet 380: 1674–1682.
5. VissersLE, de LigtJ, GilissenC, JanssenI, SteehouwerM, et al. (2010) A de novo paradigm for mental retardation. Nat Genet 42: 1109–1112.
6. Epi4K Consortium (2013) Epilepsy Phenome/GenomeP, AllenAS, BerkovicSF, CossetteP, et al. (2013) De novo mutations in epileptic encephalopathies. Nature 501: 217–221.
7. IossifovI, RonemusM, LevyD, WangZ, HakkerI, et al. (2012) De novo gene disruptions in children on the autistic spectrum. Neuron 74: 285–299.
8. NealeBM, KouY, LiuL, Ma'ayanA, SamochaKE, et al. (2012) Patterns and rates of exonic de novo mutations in autism spectrum disorders. Nature 485: 242–245.
9. O'RoakBJ, VivesL, GirirajanS, KarakocE, KrummN, et al. (2012) Sporadic autism exomes reveal a highly interconnected protein network of de novo mutations. Nature 485: 246–250.
10. SandersSJ, MurthaMT, GuptaAR, MurdochJD, RaubesonMJ, et al. (2012) De novo mutations revealed by whole-exome sequencing are strongly associated with autism. Nature 485: 237–241.
11. XuB, Ionita-LazaI, RoosJL, BooneB, WoodrickS, et al. (2012) De novo gene mutations highlight patterns of genetic and neural complexity in schizophrenia. Nat Genet 44: 1365–1369.
12. HoyerJ, EkiciAB, EndeleS, PoppB, ZweierC, et al. (2012) Haploinsufficiency of ARID1B, a member of the SWI/SNF-a chromatin-remodeling complex, is a frequent cause of intellectual disability. Am J Hum Genet 90: 565–572.
13. CarvillGL, HeavinSB, YendleSC, McMahonJM, O'RoakBJ, et al. (2013) Targeted resequencing in epileptic encephalopathies identifies de novo mutations in CHD2 and SYNGAP1. Nat Genet 45: 825–830.
14. KortumF, DasS, FlindtM, Morris-RosendahlDJ, StefanovaI, et al. (2011) The core FOXG1 syndrome phenotype consists of postnatal microcephaly, severe mental retardation, absent language, dyskinesia, and corpus callosum hypogenesis. J Med Genet 48: 396–406.
15. WillemsenMH, NijhofB, FenckovaM, NillesenWM, BongersEM, et al. (2013) GATAD2B loss-of-function mutations cause a recognisable syndrome with intellectual disability and are associated with learning deficits and synaptic undergrowth in Drosophila. J Med Genet 50: 507–514.
16. BonnetC, Ali KhanA, BressoE, VigourouxC, BeriM, et al. (2013) Extended spectrum of MBD5 mutations in neurodevelopmental disorders. Eur J Hum Genet 21: 1457–1461.
17. TalkowskiME, MullegamaSV, RosenfeldJA, van BonBW, ShenY, et al. (2011) Assessment of 2q23.1 microdeletion syndrome implicates MBD5 as a single causal locus of intellectual disability, epilepsy, and autism spectrum disorder. Am J Hum Genet 89: 551–563.
18. KleefstraT, KramerJM, NevelingK, WillemsenMH, KoemansTS, et al. (2012) Disruption of an EHMT1-associated chromatin-modification module causes intellectual disability. Am J Hum Genet 91: 73–82.
19. AsadollahiR, OnedaB, ShethF, Azzarello-BurriS, BaldingerR, et al. (2013) Dosage changes of MED13L further delineate its role in congenital heart defects and intellectual disability. Eur J Hum Genet 21: 1100–1104.
20. van HaelstMM, MonroeGR, DuranK, van BinsbergenE, BreurJM, et al. (2014) Further confirmation of the MED13L haploinsufficiency syndrome. Eur J Hum Genet
21. GilissenC, Hehir-KwaJY, ThungDT, van de VorstM, van BonBW, et al. (2014) Genome sequencing identifies major causes of severe intellectual disability. Nature 511: 344–347.
22. HoischenA, van BonBW, GilissenC, ArtsP, van LierB, et al. (2010) De novo mutations of SETBP1 cause Schinzel-Giedion syndrome. Nat Genet 42: 483–485.
23. HamdanFF, DaoudH, PatryL, Dionne-LaporteA, SpiegelmanD, et al. (2013) Parent-child exome sequencing identifies a de novo truncating mutation in TCF4 in non-syndromic intellectual disability. Clin Genet 83: 198–200.
24. NeedAC, ShashiV, HitomiY, SchochK, ShiannaKV, et al. (2012) Clinical application of exome sequencing in undiagnosed genetic conditions. J Med Genet 49: 353–361.
25. ZweierC, PeippoMM, HoyerJ, SousaS, BottaniA, et al. (2007) Haploinsufficiency of TCF4 causes syndromal mental retardation with intermittent hyperventilation (Pitt-Hopkins syndrome). Am J Hum Genet 80: 994–1001.
26. HaackTB, HogarthP, KruerMC, GregoryA, WielandT, et al. (2012) Exome sequencing reveals de novo WDR45 mutations causing a phenotypically distinct, X-linked dominant form of NBIA. Am J Hum Genet 91: 1144–1149.
27. SaitsuH, NishimuraT, MuramatsuK, KoderaH, KumadaS, et al. (2013) De novo mutations in the autophagy gene WDR45 cause static encephalopathy of childhood with neurodegeneration in adulthood. Nat Genet 45: 445–449, 449e441.
28. FilgesI, ShimojimaK, OkamotoN, RothlisbergerB, WeberP, et al. (2011) Reduced expression by SETBP1 haploinsufficiency causes developmental and expressive language delay indicating a phenotype distinct from Schinzel-Giedion syndrome. J Med Genet 48: 117–122.
29. O'RoakBJ, VivesL, FuW, EgertsonJD, StanawayIB, et al. (2012) Multiplex targeted sequencing identifies recurrently mutated genes in autism spectrum disorders. Science 338: 1619–1622.
30. PalumboO, FicheraM, PalumboP, RizzoR, MazzollaE, et al. (2014) TBR1 is the candidate gene for intellectual disability in patients with a 2q24.2 interstitial deletion. Am J Med Genet A 164(A): 828–833.
31. EndeleS, RosenbergerG, GeiderK, PoppB, TamerC, et al. (2010) Mutations in GRIN2A and GRIN2B encoding regulatory subunits of NMDA receptors cause variable neurodevelopmental phenotypes. Nat Genet 42: 1021–1026.
32. LemkeJR, HendrickxR, GeiderK, LaubeB, SchwakeM, et al. (2014) GRIN2B mutations in West syndrome and intellectual disability with focal epilepsy. Ann Neurol 75: 147–154.
33. BallifBC, RosenfeldJA, TraylorR, TheisenA, BaderPI, et al. (2012) High-resolution array CGH defines critical regions and candidate genes for microcephaly, abnormalities of the corpus callosum, and seizure phenotypes in patients with microdeletions of 1q43q44. Hum Genet 131: 145–156.
34. ThierryG, BeneteauC, PichonO, FloriE, IsidorB, et al. (2012) Molecular characterization of 1q44 microdeletion in 11 patients reveals three candidate genes for intellectual disability and seizures. Am J Med Genet A 158A: 1633–1640.
35. IskenO, MaquatLE (2007) Quality control of eukaryotic mRNA: safeguarding cells from abnormal mRNA function. Genes Dev 21: 1833–1856.
36. ZhangF, YuX (2011) WAC, a functional partner of RNF20/40, regulates histone H2B ubiquitination and gene transcription. Mol Cell 41: 384–397.
37. WentzelC, Rajcan-SeparovicE, RuivenkampCA, Chantot-BastaraudS, MetayC, et al. (2011) Genomic and clinical characteristics of six patients with partially overlapping interstitial deletions at 10p12p11. Eur J Hum Genet 19: 959–964.
38. VenetucciL, DenegriM, NapolitanoC, PrioriSG (2012) Inherited calcium channelopathies in the pathophysiology of arrhythmias. Nat Rev Cardiol 9: 561–575.
39. Van PetegemF (2012) Ryanodine receptors: structure and function. J Biol Chem 287: 31624–31632.
40. LaPageMJ, RussellMW, BradleyDJ, DickM2nd (2012) Novel ryanodine receptor 2 mutation associated with a severe phenotype of catecholaminergic polymorphic ventricular tachycardia. J Pediatr 161: 362–364.
41. JohnsonJN, TesterDJ, BassNE, AckermanMJ (2010) Cardiac channel molecular autopsy for sudden unexpected death in epilepsy. J Child Neurol 25: 916–921.
42. LehnartSE, MongilloM, BellingerA, LindeggerN, ChenBX, et al. (2008) Leaky Ca2+ release channel/ryanodine receptor 2 causes seizures and sudden cardiac death in mice. J Clin Invest 118: 2230–2245.
43. TakanoK, LiuD, TarpeyP, GallantE, LamA, et al. (2012) An X-linked channelopathy with cardiomegaly due to a CLIC2 mutation enhancing ryanodine receptor channel activity. Hum Mol Genet 21: 4497–4507.
44. MaX, BaoJ, AdelsteinRS (2007) Loss of cell adhesion causes hydrocephalus in nonmuscle myosin II-B-ablated and mutated mice. Mol Biol Cell 18: 2305–2312.
45. MaX, KawamotoS, HaraY, AdelsteinRS (2004) A point mutation in the motor domain of nonmuscle myosin II-B impairs migration of distinct groups of neurons. Mol Biol Cell 15: 2568–2579.
46. TuzovicL, YuL, ZengW, LiX, LuH, et al. (2013) A human de novo mutation in MYH10 phenocopies the loss of function mutation in mice. Rare Dis 1: e26144.
47. MutoS, SendaM, AkaiY, SatoL, SuzukiT, et al. (2007) Relationship between the structure of SET/TAF-Ibeta/INHAT and its histone chaperone activity. Proc Natl Acad Sci U S A 104: 4285–4290.
48. MinakuchiM, KakazuN, Gorrin-RivasMJ, AbeT, CopelandTD, et al. (2001) Identification and characterization of SEB, a novel protein that binds to the acute undifferentiated leukemia-associated protein SET. Eur J Biochem 268: 1340–1351.
49. LeungJW, LeitchA, WoodJL, Shaw-SmithC, MetcalfeK, et al. (2011) SET nuclear oncogene associates with microcephalin/MCPH1 and regulates chromosome condensation. J Biol Chem 286: 21393–21400.
50. JacksonAP, EastwoodH, BellSM, AduJ, ToomesC, et al. (2002) Identification of microcephalin, a protein implicated in determining the size of the human brain. Am J Hum Genet 71: 136–142.
51. PoirierR, ChevalH, MailhesC, GarelS, CharnayP, et al. (2008) Distinct functions of egr gene family members in cognitive processes. Front Neurosci 2: 47–55.
52. BozonB, DavisS, LarocheS (2002) Regulated transcription of the immediate-early gene Zif268: mechanisms and gene dosage-dependent function in synaptic plasticity and memory formation. Hippocampus 12: 570–577.
53. JonesMW, ErringtonML, FrenchPJ, FineA, BlissTV, et al. (2001) A requirement for the immediate early gene Zif268 in the expression of late LTP and long-term memories. Nat Neurosci 4: 289–296.
54. DickeyAS, StrackS (2011) PKA/AKAP1 and PP2A/Bbeta2 regulate neuronal morphogenesis via Drp1 phosphorylation and mitochondrial bioenergetics. J Neurosci 31: 15716–15726.
55. MuntonRP, ViziS, MansuyIM (2004) The role of protein phosphatase-1 in the modulation of synaptic and structural plasticity. FEBS Lett 567: 121–128.
56. Stuchell-BreretonMD, SkalickyJJ, KiefferC, KarrenMA, GhaffarianS, et al. (2007) ESCRT-III recognition by VPS4 ATPases. Nature 449: 740–744.
57. McCulloughJ, ColfLA, SundquistWI (2013) Membrane fission reactions of the mammalian ESCRT pathway. Annu Rev Biochem 82: 663–692.
58. MoritaE, ColfLA, KarrenMA, SandrinV, RodeschCK, et al. (2010) Human ESCRT-III and VPS4 proteins are required for centrosome and spindle maintenance. Proc Natl Acad Sci U S A 107: 12889–12894.
59. ZuberiK, FranzM, RodriguezH, MontojoJ, LopesCT, et al. (2013) GeneMANIA prediction server 2013 update. Nucleic Acids Res 41: W115–122.
60. FroyenG, CorbettM, VandewalleJ, JarvelaI, LawrenceO, et al. (2008) Submicroscopic duplications of the hydroxysteroid dehydrogenase HSD17B10 and the E3 ubiquitin ligase HUWE1 are associated with mental retardation. Am J Hum Genet 82: 432–443.
61. WangK, LiM, HakonarsonH (2010) ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data. Nucleic Acids Res 38: e164.
62. RobinsonJT, ThorvaldsdottirH, WincklerW, GuttmanM, LanderES, et al. (2011) Integrative genomics viewer. Nat Biotechnol 29: 24–26.